iBio, Inc. (IBIO)

NASDAQ

$0.71

$-0.09

(-11.06%)

Regular Market

iBio, Inc. (IBIO) Live Price Chart

Last updated: ⁦2026-11-05 17:55:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

iBio, Inc. (IBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.71, with a market capitalization of $52.96M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.69 to $3.82. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$52.96M
Open	$0.78
Day's High	$30,300.00
Day's Low	$0.56
Previous Close	$0.80
Volume	451.29K
Average Volume	708.93K
P/E Ratio	--
52-Week High	$3.82
52-Week Low	$0.69
Dividend Yield	--
Earnings Date	--

iBio, Inc. (IBIO) Stock Price Today

iBio, Inc. (IBIO) is currently trading at $0.71 as of 2026-11-05 17:38:28, down 10.88% ($0.09) from the previous close of $0.80

During today's regular trading session, IBIO has traded between $0.56 and $30,300.00, with a trading volume of 451.29K shares. The current price is near the lower end of today's range.

iBio, Inc. (IBIO) 7-Day Stock Price Change

Over the past seven days, iBio, Inc. (IBIO) moved from $0.77 to $0.71, representing a decline of 7.03% ($0.05).

The stock traded between $0.69 and $0.86 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 316.60 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

IBIO 52-Week Price Position

Position in Range: 0.9%

52W Low$0.69

52W High$3.82

IBIO is currently trading at $0.71, placing it 0.9% of the way from its 52-week low of $0.69 to its 52-week high of $3.82. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is iBio, Inc. (IBIO)?

iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.

iBio, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	23
Exchange	NASDAQ
Company Website	https://www.ibioinc.com

How to Buy iBio, Inc. (IBIO) Stock on MEXC

Eligible investors can buy real shares of iBio, Inc. (IBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IBIO and Place Your Order

Open the RealStocks trading page and search for IBIO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is iBio, Inc. (IBIO) stock price today?

iBio, Inc. (IBIO) is currently trading at $ 0.71, down 10.88% ($0.09) from the previous close of $ 0.80. Intraday prices update in real time during regular trading hours.

2.Is IBIO stock going up or down today?

As of 2026-11-05 17:38:28, IBIO is trading at $ 0.71, down 10.88% ($0.09) from its previous close of $ 0.80. The stock has traded between $ 0.56 and $ 30,300.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is IBIO pre-market price?

As of 2026-11-05 17:38:28, IBIO is trading at $ 0.81 in pre-market trading, up 1.13% ($0.01) from the previous close of $ 0.80. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IBIO after-hours price?

As of 2026-11-05 17:38:28, IBIO is trading at $ 0.81 in after-hours trading, up 1.25% ($0.01) from the regular-session close of $ 0.80. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IBIO stock trading now?

IBIO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IBIO sit relative to its 52-week high and low?

Over the past 52 weeks, IBIO has traded between a low of $ 0.69 and a high of $ 3.82. At $ 0.71, the stock is positioned 0.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is iBio, Inc. in?

iBio, Inc. (IBIO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is iBio, Inc.'s market capitalization and where is it listed?

iBio, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 52.96M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IBIO valued in terms of P/E ratio and EPS?

IBIO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.37. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does iBio, Inc. pay a dividend?

iBio, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.